Monitor
Quote
Charts
Trades
News
Financials
Toplists
Alerts
Portfolio
Level 2
Message Boards
25/07/2008
17:22:00
Site map
<a href="http://as1.advfn.com/oasis/oasisc.php?s=558&w=468&h=60&ord=1217020920&t=_blank" target="_blank" rel='nofollow'> <img src="http://as1.advfn.com/oasis/oasisi.php?s=558&w=468&h=60&ord=1217020920&t=_blank" border='0' width='468' height='60'></a>
Help
<a href="http://as1.advfn.com/oasis/oasisc.php?s=583&w=120&h=30&ord=1217020920&t=_blank" target="_blank" rel='nofollow'> <img src="http://as1.advfn.com/oasis/oasisi.php?s=583&w=120&h=30&ord=1217020920&t=_blank" border='0' width='120' height='30'></a>
<a href="http://as1.advfn.com/oasis/oasisc.php?s=584&w=120&h=30&ord=1217020920&t=_blank" target="_blank" rel='nofollow'> <img src="http://as1.advfn.com/oasis/oasisi.php?s=584&w=120&h=30&ord=1217020920&t=_blank" border='0' width='120' height='30'></a>
<a href="http://as1.advfn.com/oasis/oasisc.php?s=585&w=120&h=30&ord=1217020920&t=_blank" target="_blank" rel='nofollow'> <img src="http://as1.advfn.com/oasis/oasisi.php?s=585&w=120&h=30&ord=1217020920&t=_blank" border='0' width='120' height='30'></a>
<a href="http://as1.advfn.com/oasis/oasisc.php?s=586&w=120&h=30&ord=1217020920&t=_blank" target="_blank" rel='nofollow'> <img src="http://as1.advfn.com/oasis/oasisi.php?s=586&w=120&h=30&ord=1217020920&t=_blank" border='0' width='120' height='30'></a>
<a href="http://as1.advfn.com/oasis/oasisc.php?s=2115&w=120&h=30&ord=1217020920&t=_blank" target="_blank" rel='nofollow'> <img src="http://as1.advfn.com/oasis/oasisi.php?s=2115&w=120&h=30&ord=1217020920&t=_blank" border='0' width='120' height='30'></a>
<a href="http://as1.advfn.com/oasis/oasisc.php?s=2116&w=120&h=30&ord=1217020920&t=_blank" target="_blank" rel='nofollow'> <img src="http://as1.advfn.com/oasis/oasisi.php?s=2116&w=120&h=30&ord=1217020920&t=_blank" border='0' width='120' height='30'></a>
Seattle Genetics News
(NASDAQ:SGEN)
Seattle Genetics stock quote
|
Seattle Genetics company information
|
Seattle Genetics Stock Chart
|
Seattle Genetics Stock News
Latest Seattle Genetics News Headlines
Date
Time
Source
Headline
06/01/2008
6:00PM
PRNUS
CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma
- Data presented at the 2008 ASCO Annual Meeting - BRANFORD, Conn., June 1 /PRNewswire-FirstCall/ -- CuraGen Corporation (NASDAQ:CRGN) today presented encouraging results from the ongoing Phase I/II study of CR011-vcMMAE for the treatment of unresectable Stage III or Stage IV melanoma. The results were presented by...
More...>>
10/24/2007
4:05PM
PRNUS
CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma
- Initial clinical trial results suggesting safety and clinical activity of CR011-vcMMAE reported at the AACR-NCI-EORTC International Conference - BRANFORD, Conn., Oct. 24 /PRNewswire-FirstCall/ -- CuraGen Corporation (NASDAQ:CRGN), a clinical-stage biopharmaceutical company focused on oncology, announced that the first...
More...>>
12/08/2005
9:29AM
PRNUS
MedImmune Licensing New Antibody-Enhancing Technologies to Further Strengthen its Development-Stage Pipeline
GAITHERSBURG, Md., Dec. 8 /PRNewswire-FirstCall/ -- MedImmune, Inc. (NASDAQ:MEDI) announced today that it continues to build upon its corporate initiatives to expand and expedite the development of its product pipeline by licensing rights to antibody-enhancing technologies. The latest technology agreements MedImmune...
More...>>
06/22/2005
8:01AM
PRNUS
Protein Design Labs Sublicenses Rights to Develop Antibody-Drug Conjugates for Prostate Cancer to Genentech, Inc.
Protein Design Labs Sublicenses Rights to Develop Antibody-Drug Conjugates for Prostate Cancer to Genentech, Inc. Program Utilizes Seattle Genetics' ADC technology FREMONT, Calif., June 22 /PRNewswire-FirstCall/ -- Protein Design Labs, Inc. (PDL) (NASDAQ:PDLI) today reported that it has sublicensed to Genentech, Inc. (NYSE:DNA...
More...>>
<a href="http://as1.advfn.com/oasis/oasisc.php?s=2217&w=120&h=600&ord=1217020920&t=_blank" target="_blank" rel='nofollow'> <img src="http://as1.advfn.com/oasis/oasisi.php?s=2217&w=120&h=600&ord=1217020920&t=_blank" border='0' width='120' height='600'></a>
<a href="http://as1.advfn.com/oasis/oasisc.php?s=2398&w=728&h=90&ord=1217020920&t=_blank" target="_blank" rel='nofollow'> <img src="http://as1.advfn.com/oasis/oasisi.php?s=2398&w=728&h=90&ord=1217020920&t=_blank" border='0' width='728' height='90'></a>
LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's
Terms & Conditions
::
Contact Us
::
Request an Exchange
::
Affiliate Scheme
Copyright1999-2008 ADVFN PLC.
Copyright and limited reproduction
::
Privacy Policy
::
Investment Warning
::
Advertise with us
::
Data accreditations
::
Investor Relations
::
Press office
::
Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
30 site:2us nasdaq sgen080725 17:22
Stock Message Boards
(
2001
|
2002
|
2003
|
2004
|
2005
|
2005
|
2007
)